Immedica appoints Johannes Fabó as Chief Financial Officer
Pharmaceutical company Immedica has appointed Johannes Fabó as its new CFO, effective November 4, 2026. He will join the company's executive leadership team.
Immedica has named Johannes Fabó as its Chief Financial Officer, effective November 4, 2026. As part of his new role, Fabó will also join the company's executive leadership team, where he will oversee the firm's financial operations.
Fabó joins the organization with an extensive background in finance, strategy, and operations across the healthcare and industrial sectors. Most recently, he served as CFO at Cambio, a Swedish health-tech company specializing in electronic health record systems for the Nordic market. His previous professional experience includes various senior financial management roles.
This appointment marks a strategic shift in Immedica’s corporate governance as the company seeks to align its financial leadership with its ongoing operational objectives.